Advisor Group Holdings, Inc. In Med Pharmaceuticals Inc. Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
A detailed history of Advisor Group Holdings, Inc. transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 32 shares of INM stock, worth $7. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 41
21.95%
Holding current value
$7
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding INM
# of Institutions
16Shares Held
463KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ307KShares$73,7365.39% of portfolio
-
Virtu Financial LLC New York, NY86.7KShares$20,8040.0% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M22.6KShares$5,4260.0% of portfolio
-
Xtx Topco LTD London, X017.8KShares$4,2760.0% of portfolio
-
Hrt Financial LP New York, NY16KShares$3,8390.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $218K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...